NPASS Compound

Natural Product: NPC491020

Natural Product ID	NPC491020
Common Name ? The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.	Zeaxanthin
IUPAC Name	(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol
Synonyms
Synthetic Gene Cluster	n.a.
ChEMBL Identifier	n.a.
PubChem CID	5280899
Chemical Classification	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000012] Lipids and lipid-like molecules [CHEMONTID:0000259] Prenol lipids [CHEMONTID:0001554] Tetraterpenoids [CHEMONTID:0001277] Carotenoids [CHEMONTID:0001410] Xanthophylls

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

Chemical Representations

RDKit 3D 98 99 0 0 0 0 0 0 0 0999 V2000 -12.2168 2.5068 1.3684 C 0 0 0 0 0 0 0 0 0 0 0 0 -12.5292 1.2446 0.5962 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.5247 0.5084 0.1616 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.7331 -0.7211 -0.5892 C 0 0 0 0 0 0 0 0 0 0 0 0 -13.1805 -1.0585 -0.8852 C 0 0 0 0 0 0 0 0 0 0 0 0 -14.0500 0.1676 -0.9348 C 0 0 1 0 0 0 0 0 0 0 0 0 -13.9650 0.9171 0.3794 C 0 0 0 0 0 0 0 0 0 0 0 0 -13.6434 0.9559 -1.9879 O 0 0 0 0 0 0 0 0 0 0 0 0 -11.0516 -0.6074 -1.9406 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.0909 -1.8843 0.1726 C 0 0 0 0 0 0 0 0 0 0 0 0 -10.1749 0.9711 0.4557 C 0 0 0 0 0 0 0 0 0 0 0 0 -9.0635 0.3810 0.1126 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.7311 0.9041 0.4428 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.6764 0.1962 0.0281 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3313 0.6692 0.3267 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2613 0.0092 -0.0548 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9122 0.4191 0.2054 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8935 -0.3450 -0.2349 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5154 0.0439 0.0124 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5410 -0.6438 -0.3762 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8990 -0.2007 -0.0975 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9491 -0.9196 -0.4969 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3038 -0.4573 -0.2083 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4110 -1.0749 -0.5442 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7143 -0.5260 -0.2073 C 0 0 0 0 0 0 0 0 0 0 0 0 7.8060 -1.1887 -0.5622 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1137 -0.5897 -0.1983 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2740 -1.1022 -0.4662 C 0 0 0 0 0 0 0 0 0 0 0 0 11.5108 -0.4565 -0.0775 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6454 -1.0910 -0.4140 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9947 -0.5699 -0.0939 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9045 0.9465 -0.0941 C 0 0 2 0 0 0 0 0 0 0 0 0 12.9181 1.3031 0.9756 C 0 0 0 0 0 0 0 0 0 0 0 0 11.5141 0.8239 0.6471 C 0 0 0 0 0 0 0 0 0 0 0 0 10.8511 1.9567 -0.0988 C 0 0 0 0 0 0 0 0 0 0 0 0 10.8183 0.6835 2.0072 C 0 0 0 0 0 0 0 0 0 0 0 0 13.5507 1.4361 -1.3446 O 0 0 0 0 0 0 0 0 0 0 0 0 12.5517 -2.3995 -1.1524 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6406 -2.4510 -1.2698 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6374 -2.1679 -1.2211 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5128 1.6339 0.9340 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.4437 2.1279 1.1891 C 0 0 0 0 0 0 0 0 0 0 0 0 -11.6168 3.1749 0.7425 H 0 0 0 0 0 0 0 0 0 0 0 0 -11.5996 2.2459 2.2768 H 0 0 0 0 0 0 0 0 0 0 0 0 -13.1401 3.0064 1.6523 H 0 0 0 0 0 0 0 0 0 0 0 0 -13.2758 -1.5831 -1.8491 H 0 0 0 0 0 0 0 0 0 0 0 0 -13.5628 -1.7137 -0.0763 H 0 0 0 0 0 0 0 0 0 0 0 0 -15.0966 -0.1420 -1.0814 H 0 0 0 0 0 0 0 0 0 0 0 0 -14.5420 1.8567 0.2527 H 0 0 0 0 0 0 0 0 0 0 0 0 -14.3918 0.3169 1.1902 H 0 0 0 0 0 0 0 0 0 0 0 0 -13.5568 1.9032 -1.7012 H 0 0 0 0 0 0 0 0 0 0 0 0 -10.5422 0.3776 -2.0835 H 0 0 0 0 0 0 0 0 0 0 0 0 -11.8588 -0.5916 -2.7324 H 0 0 0 0 0 0 0 0 0 0 0 0 -10.4280 -1.4776 -2.1939 H 0 0 0 0 0 0 0 0 0 0 0 0 -10.4562 -2.5000 -0.4764 H 0 0 0 0 0 0 0 0 0 0 0 0 -10.5853 -1.5705 1.0934 H 0 0 0 0 0 0 0 0 0 0 0 0 -11.9396 -2.5758 0.4663 H 0 0 0 0 0 0 0 0 0 0 0 0 -10.0298 1.9163 1.0248 H 0 0 0 0 0 0 0 0 0 0 0 0 -9.1331 -0.5460 -0.4451 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.8183 -0.7203 -0.5249 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.2105 1.5821 0.8714 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4474 -0.9104 -0.6063 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.1188 -1.2436 -0.7701 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.2812 0.9674 0.5559 H 0 0 0 0 0 0 0 0 0 0 0 0 0.3647 -1.5587 -0.9175 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0711 0.7283 0.4433 H 0 0 0 0 0 0 0 0 0 0 0 0 4.4251 0.4814 0.3329 H 0 0 0 0 0 0 0 0 0 0 0 0 5.3273 -2.0042 -1.0820 H 0 0 0 0 0 0 0 0 0 0 0 0 6.7625 0.4184 0.3299 H 0 0 0 0 0 0 0 0 0 0 0 0 9.0889 0.3522 0.3340 H 0 0 0 0 0 0 0 0 0 0 0 0 10.2847 -2.0535 -1.0062 H 0 0 0 0 0 0 0 0 0 0 0 0 14.7474 -0.9352 -0.8180 H 0 0 0 0 0 0 0 0 0 0 0 0 14.2178 -0.8671 0.9553 H 0 0 0 0 0 0 0 0 0 0 0 0 14.8974 1.3369 0.2114 H 0 0 0 0 0 0 0 0 0 0 0 0 13.2576 0.8343 1.9181 H 0 0 0 0 0 0 0 0 0 0 0 0 12.8851 2.4189 1.1167 H 0 0 0 0 0 0 0 0 0 0 0 0 10.4876 1.6238 -1.0956 H 0 0 0 0 0 0 0 0 0 0 0 0 11.6163 2.7452 -0.3451 H 0 0 0 0 0 0 0 0 0 0 0 0 10.0908 2.5010 0.4991 H 0 0 0 0 0 0 0 0 0 0 0 0 10.0689 1.4732 2.1820 H 0 0 0 0 0 0 0 0 0 0 0 0 10.4257 -0.3497 2.1579 H 0 0 0 0 0 0 0 0 0 0 0 0 11.5540 0.8092 2.8541 H 0 0 0 0 0 0 0 0 0 0 0 0 13.3259 0.7205 -1.9690 H 0 0 0 0 0 0 0 0 0 0 0 0 11.9646 -3.1095 -0.5294 H 0 0 0 0 0 0 0 0 0 0 0 0 12.0378 -2.2224 -2.1092 H 0 0 0 0 0 0 0 0 0 0 0 0 13.5442 -2.8127 -1.3305 H 0 0 0 0 0 0 0 0 0 0 0 0 8.5963 -2.9788 -1.3581 H 0 0 0 0 0 0 0 0 0 0 0 0 6.9519 -3.1279 -0.6748 H 0 0 0 0 0 0 0 0 0 0 0 0 7.1802 -2.2342 -2.2703 H 0 0 0 0 0 0 0 0 0 0 0 0 3.5215 -2.7862 -1.3917 H 0 0 0 0 0 0 0 0 0 0 0 0 2.1933 -1.8780 -2.2047 H 0 0 0 0 0 0 0 0 0 0 0 0 1.9305 -2.7948 -0.6092 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.8489 1.3536 1.7804 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.3861 2.1432 1.3304 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.9945 2.2963 0.2048 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.7991 1.9076 2.0914 H 0 0 0 0 0 0 0 0 0 0 0 0 -8.3333 2.6278 1.5953 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.8734 2.8172 0.5228 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 1 0 5 6 1 0 6 7 1 0 6 8 1 0 4 9 1 0 4 10 1 0 3 11 1 0 11 12 2 0 12 13 1 0 13 14 2 0 14 15 1 0 15 16 2 0 16 17 1 0 17 18 2 0 18 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 22 23 1 0 23 24 2 0 24 25 1 0 25 26 2 0 26 27 1 0 27 28 2 0 28 29 1 0 29 30 2 0 30 31 1 0 31 32 1 0 32 33 1 0 33 34 1 0 34 35 1 0 34 36 1 0 32 37 1 0 30 38 1 0 26 39 1 0 22 40 1 0 17 41 1 0 13 42 1 0 7 2 1 0 34 29 1 0 1 43 1 0 1 44 1 0 1 45 1 0 5 46 1 0 5 47 1 0 6 48 1 6 7 49 1 0 7 50 1 0 8 51 1 0 9 52 1 0 9 53 1 0 9 54 1 0 10 55 1 0 10 56 1 0 10 57 1 0 11 58 1 0 12 59 1 0 14 60 1 0 15 61 1 0 16 62 1 0 18 63 1 0 19 64 1 0 20 65 1 0 21 66 1 0 23 67 1 0 24 68 1 0 25 69 1 0 27 70 1 0 28 71 1 0 31 72 1 0 31 73 1 0 32 74 1 1 33 75 1 0 33 76 1 0 35 77 1 0 35 78 1 0 35 79 1 0 36 80 1 0 36 81 1 0 36 82 1 0 37 83 1 0 38 84 1 0 38 85 1 0 38 86 1 0 39 87 1 0 39 88 1 0 39 89 1 0 40 90 1 0 40 91 1 0 40 92 1 0 41 93 1 0 41 94 1 0 41 95 1 0 42 96 1 0 42 97 1 0 42 98 1 0 M END

Standard InCHIKey	JKQXZKUSFCKOGQ-QAYBQHTQSA-N
Standard InCHI	InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-24,35-36,41-42H,25-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36-/m1/s1
SMILES	CC1=C(C(C[C@@H](C1)O)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(C[C@H](CC2(C)C)O)C)\C)\C)/C)/C

Calculated Properties

Physi-Chem Properties

Molecular Weight:	568.43	Volume:	671.862 ? Van der Waals volume.
Dense:	0.846	LogP:	5.193 ? The logarithm of the n-octanol/water distribution coefficients.
logD7.4:	4.046 ? The logarithm of the n-octanol/water distribution coefficient at pH=7.4.	LogS:	-6.052 ? The logarithm of aqueous solubility value.
Rotatable Bonds:	10.0	Rigid Bonds:	21.0
TPSA:	40.46 ? Topological Polar Surface Area.	H-Bond Acceptor:	2.0
H-Bond Donor:	2.0	Rings:	2.0
Heavy Atoms:	2.0

MedChem Properties

QED Drug-Likeness Score:	0.257	GASA:	1.0 ? GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:	4.577	Fsp³:	0.45
MCE-18:	50.069 ? MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.	Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Accepted	GSK Rule:	Accepted
Golden Triangle Rule:	Accepted	BMS Rule:	1
Chelating Alert:	0	PAINS Alert:	0
Colloidal aggregators:	1.0	Fluc inhibitor:	0.657 ? The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:	0.067 ? The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1	Green fluorescence:	0.02 ? The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:	0.666	Promiscuous compounds:	0.239

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:	-5.069	MDCK Permeability:	-4.803
Pgp-inhibitor:	0.059	Pgp-substrate:	0.998
PAMPA:	0.96 ? The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).	Human Intestinal Absorption (HIA):	0.0
20% Bioavailability (F20%):	0.666	30% Bioavailability (F30%):	0.71
50% Bioavailability (F50%):	1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.0	MRP1:	0.906
Plasma Protein Binding (PPB):	92.477%	Volume Distribution (VD):	0.173
Fu:	9.874% ? The fraction unbound in plasms.	OATP1B1 inhibitor:	1.0
OATP1B3 inhibitor:	0.995	BCRP inhibitor:	0.123
BSEP inhibitor:	1.0

ADMET: Metabolism

CYP1A2-inhibitor:	0.002	CYP1A2-substrate:	0.0
CYP2C19-inhibitor:	0.0	CYP2C19-substrate:	0.0
CYP2C9-inhibitor:	0.0	CYP2C9-substrate:	0.227
CYP2D6-inhibitor:	0.001	CYP2D6-substrate:	0.001
CYP3A4-inhibitor:	0.0	CYP3A4-substrate:	0.992
CYP2B6-substrate:	0.0	CYP2C8-inhibitor:	0.999
HLM stability:	0.434 ? Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):

9.269

Half-life (T1/2):

0.602

ADMET: Toxicity

hERG Blockers:	0.119	hERG Blockers (10um):	0.237
Human Hepatotoxicity (H-HT):	0.487	Drug-induced Liver Injury (DILI):	0.301
AMES Toxicity:	0.703	Rat Oral Acute Toxicity:	0.405
Maximum Recommended Daily Dose:	0.925	Skin Sensitization:	0.982
Carcinogencity:	0.772	Eye Corrosion:	0.001
Eye Irritation:	0.344	Respiratory Toxicity:	0.542
Drug-induced Neurotoxicity:	0.635	Ototoxicity:	0.872
Hematotoxicity:	0.33	Drug-induced Nephrotoxicity:	0.954
Genotoxicity:	0.158	RPMI-8226 Immunitoxicity:	0.137
A549 Cytotoxicity:	0.255	Hek293 Cytotoxicity:	0.549
BCF:	2.587 ? Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].	IGC50:	4.645 ? 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:	6.221 ? 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].	LC50FM:	5.881 ? 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO41688	Escherichia coli JCL260 [alsS, kivD, ilvC, ilvD, adhA adhE frdBC fnr ldhA pta pflB]	Strain	Enterobacteriaceae	Bacteria	n.a.	n.a.	n.a.	PMID[21547458]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[28684180]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[31624503]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[32840573]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[32923433]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[33605546]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[33938153]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	PMID[36867718]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1007/s00253-019-09627-z]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1007/s00253-019-09735-w]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1007/s12257-018-0497-9]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.bej.2018.05.023]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.biortech.2022.128178]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ces.2018.10.052]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ces.2020.115529]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.jbiotec.2018.07.001]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.jbiotec.2018.11.009]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.mec.2019.e00121]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.mec.2022.e00197]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.synbio.2017.10.002]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ymben.2016.07.001]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ymben.2017.04.004]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ymben.2019.05.002]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ymben.2021.03.010]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1016/j.ymben.2022.06.001]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1021/acs.jafc.0c06504]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1021/acssynbio.1c00480]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1039/D0GC03180A]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1128/AEM]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s12934-018-0984-x]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s12934-019-1127-8]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s12934-019-1136-7]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s12934-020-01309-0]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s13068-016-0593-z]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.1186/s13068-020-01773-1]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.3389/fmicb.2021.699235]
NPO65069	A new engineered strain of Yarrowia lipolytica	Species	n.a.	n.a.	n.a.	n.a.	n.a.	DOI[https://doi.org/10.3390/microorganisms7100472]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	Organism Name	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Molecular-level activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vitro activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vivo activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

Experimental ADME

Experiment Model	Experiment Tissue	ADME Type	ADME Relation	ADME Value	ADME Unit	Reference

Experimental Toxicity

Quantitative toxicity

Experiment Model	Experiment Organism	Toxicity Type	Toxicity Relation	Toxicity Value	Toxicity Unit	Reference
-	Rattus norvegicus	NOAEL	=	150.0	mg/kg-day	ToxVal

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity	Carcinogenicity	Mutagenicity	Cardiotoxicity	Respiratory Toxicity	Eye Irritation	Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]

Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

● The left chart: Distribution of similarity level between NPC491020 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	32925
0.1-0.2	16665
0.2-0.3	228
0.3-0.4	14
0.4-0.5	15
0.5-0.6	5
0.6-0.7	0
0.7-0.8	1
0.8-0.85	1
0.85-0.9	0
0.9-0.95	0
0.95-1	1

Similarity Score	Similarity Level	Natural Product ID
1.0	High Similarity	NPC45782
0.8108	Intermediate Similarity	NPC606837
0.7381	Intermediate Similarity	NPC607338
0.7209	Intermediate Similarity	NPC171148
0.7209	Intermediate Similarity	NPC313179
0.7209	Intermediate Similarity	NPC69383
0.7209	Intermediate Similarity	NPC183736
0.5714	Remote Similarity	NPC74086
0.5676	Remote Similarity	NPC17810
0.5676	Remote Similarity	NPC606095
0.5238	Remote Similarity	NPC55412
0.5238	Remote Similarity	NPC249645

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC491020 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	8315
0.1-0.2	813
0.2-0.3	10
0.3-0.4	6
0.4-0.5	2
0.5-0.6	3
0.6-0.7	0
0.7-0.8	1
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
0.7209	Intermediate Similarity	NPD8264	Approved
0.5714	Remote Similarity	NPD8259	Clinical (unspecified phase)
0.5676	Remote Similarity	NPD8262	Phase 4
0.5238	Remote Similarity	NPD4219	Phase 4

Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data